
Vice President API MSAT Quality Control in CMC & Product Supply, Kalundborg (Denmark)
Are you an experienced leader of large-scale quality control organisations in technically complex lab and analytical settings? Can you combine strategic vision with hands‑on execution to drive innovation, operational excellence, and uncompromising API quality control? If so, we invite you to join Novo Nordisk as our new Vice President of Quality Control (QC) within Active Pharmaceutical Ingredient (API) Manufacturing Science & Technology (MSAT). Read on and apply today to make an indispensable difference in the consistent, high-quality production of our life-saving medicines.
The position
As the Vice President of Quality Control, you will assume leadership over critical aspects of our Active Pharmaceutical Ingredient (API) manufacturing pipeline. This role demands a strong focus on compliance, process mastery, and future-proofing our operations through advanced technol-ogy adoption.
Quality control (QC) within API MSAT is a newly created organisation consisting of four Director-led areas with 330 highly qualified lab technicians and professionals based in several facilitates in Kalundborg, Denmark. The task is to centralise the new organisation under the new leadership and ensure one smooth operation capable of handling the ever-increasing demands of a growing organisation and evolving pipeline.
In this high-impact role, you will:
The role is based in Kalundborg, Denmark.
Qualifications
We are looking for an experienced and innovative leader with a proven track record of success in managing complex, compliant manufacturing environments.
The successful candidate will possess:
About the organisation
Active Pharmaceutical Ingredient (API) Manufacturing Science & Technology (MSAT) is a depart-ment within Novo Nordisk’s Product Supply organisation. The department is at the forefront of bridging clinical development and manufacturing at Novo Nordisk. Our mission is to support the present and future manufacturing of Active Pharmaceutical Ingredients (APIs) through:
Working at Novo Nordisk
Every day we seek the solutions that defeat serious chronic diseases. To do this, we approach our work with an unconventional spirit, a rare determination, and a constant curiosity. For over 100 years, this unordinary mindset has seen us build a company unlike any other. One where a collec-tive passion for our purpose, mutual respect, and a willingness to go beyond what we know de-livers extraordinary results.
Novo Nordisk is currently in the process of adjusting job titles globally. Please note that the job title listed in this advertisement may be subject to change. More detailed information will be provided during the recruitment process.”
Contact and Deadline
For further information, please contact Executive Search Partner, Heidi Ashby at HZEA@novonordisk.com or get to know us better by visiting www.novonordisk.com/careers Apply by Sunday 11th of January.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic diseases and promote long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and treat, prevent, and even cure diseases that affect millions of lives. Because it takes an unordinary approach to drive real, lasting change in health.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html